1 Nov 2022 , 02:21 PM
Net profit of Sun Pharmaceuticals Industries rose 10.51% to Rs 2262.22 crore in the quarter ended September 2022 as against Rs 2047.01 crore during the previous quarter ended September 2021. Sales rose 13.11% to Rs 10809.19 crore in the quarter ended September 2022 as against Rs 9556.74 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 10809.19 | 9556.74 | 13 |
| OPM % | 27.35 | 27.52 | – |
| PBDT | 3022.38 | 2816.88 | 7 |
| PBT | 2412.43 | 2286.51 | 6 |
| NP | 2262.22 | 2047.01 | 11 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
